The European Research Infrastructure on Highly pathogenic Agents (ERINHA) launches special SARS-CoV-2/Covid-19 call to access ERINHA facilities free of charge

The European Research Infrastructure on Highly pathogenic Agents (ERINHA), supported by the EU funded H2020 project ERINHA-Advance, has announced a call for proposals specifically dedicated to COVID-19 / SARS-CoV-2 research.

Following the many European projects and initiatives ERINHA and its members have undertaken to date to advance COVID-19 / SARS-CoV-2 research, this new call will offer the selected scientists and their projects free of charge transnational access (TNA) to the ERINHA cutting edge, high containment facilities.
The priority topics to be covered are:

  • Diagnosis tools & Immunological Tests for COVID 19 / SARS CoV 2
  • Therapeutics against COVID 19 / SARS CoV 2
  • Vaccines against SARS CoV 2
  • Process development
  • Other Tools & Methods related to COVID 19 / SARS CoV 2

Proposals should be submitted by June 22, 2020 for priority access.

ERINHA is a pan-European distributed non-profit research infrastructure providing access to high containment facilities, training and expertise to promote research on infectious diseases.

Full request for ERINHA proposal

EU Flag

The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101094188.